Literature DB >> 18563792

Summarizing differences in cumulative incidence functions.

Mei-Jie Zhang1, Jason Fine.   

Abstract

The cumulative incidence function is widely reported in competing risks studies, with group differences assessed by an extension of the log-rank test. However, simple, interpretable summaries of group differences are not available. An adaptation of the proportional hazards model to the cumulative incidence function is often employed, but the interpretation of the hazard ratio may be somewhat awkward, unlike the usual survival set-up. We propose nonparametric inferences for general summary measures, which may be time-varying, and for time-averaged versions of the measures. Theoretical justification is provided using counting process techniques. A real data example illustrates the practical utility of the methods. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18563792      PMCID: PMC3310382          DOI: 10.1002/sim.3339

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Regression modeling of competing crude failure probabilities.

Authors:  J P Fine
Journal:  Biostatistics       Date:  2001-03       Impact factor: 5.899

3.  Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function.

Authors:  John P Klein; Per Kragh Andersen
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

4.  Non-parametric inference for cumulative incidence functions in competing risks studies.

Authors:  D Y Lin
Journal:  Stat Med       Date:  1997-04-30       Impact factor: 2.373

5.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

6.  Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

Authors:  Jorge Sierra; Waleska S Pérez; Ciril Rozman; Enric Carreras; John P Klein; J Douglas Rizzo; Stella M Davies; Hillard M Lazarus; Christopher N Bredeson; David I Marks; Carmen Canals; Marc A Boogaerts; John Goldman; Richard E Champlin; Armand Keating; Daniel J Weisdorf; Theo M de Witte; Mary M Horowitz
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

  6 in total
  16 in total

1.  SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models.

Authors:  Xu Zhang; Mei-Jie Zhang
Journal:  Comput Methods Programs Biomed       Date:  2010-08-17       Impact factor: 5.428

2.  Adaptive NK cell reconstitution is associated with better clinical outcomes.

Authors:  Frank Cichocki; Emily Taras; Flavia Chiuppesi; John E Wagner; Bruce R Blazar; Claudio Brunstein; Xianghua Luo; Don J Diamond; Sarah Cooley; Daniel J Weisdorf; Jeffrey S Miller
Journal:  JCI Insight       Date:  2019-01-24

3.  Weighted comparison of two cumulative incidence functions with R-CIFsmry package.

Authors:  Jianing Li; Jennifer Le-Rademacher; Mei-Jie Zhang
Journal:  Comput Methods Programs Biomed       Date:  2014-06-11       Impact factor: 5.428

4.  B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.

Authors:  R M Saliba; S Sarantopoulos; C L Kitko; A Pawarode; S C Goldstein; J Magenau; A M Alousi; T Churay; H Justman; S Paczesny; P Reddy; D R Couriel
Journal:  Bone Marrow Transplant       Date:  2017-05-08       Impact factor: 5.483

Review 5.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.

Authors:  Steven Z Pavletic; Shaji Kumar; Mohamad Mohty; Marcos de Lima; James M Foran; Marcelo Pasquini; Mei-Jie Zhang; Sergio Giralt; Michael R Bishop; Daniel Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2010-04-24       Impact factor: 5.742

6.  Comparing center-specific cumulative incidence functions.

Authors:  Ludi Fan; Douglas E Schaubel
Journal:  Lifetime Data Anal       Date:  2015-03-20       Impact factor: 1.588

7.  Frailty Risks of Prescription Analgesics and Sedatives across Frailty Models: the Health and Retirement Study.

Authors:  Andrew W Bergen; Gulcan Cil; Lana J Sargent; Chintan V Dave
Journal:  Drugs Aging       Date:  2022-05-20       Impact factor: 3.923

8.  Patient death as a censoring event or competing risk event in models of nursing home placement.

Authors:  Jeff M Szychowski; David L Roth; Olivio J Clay; Mary S Mittelman
Journal:  Stat Med       Date:  2010-02-10       Impact factor: 2.373

9.  A Proportional Hazards Regression Model for the Sub-distribution with Covariates Adjusted Censoring Weight for Competing Risks Data.

Authors:  Peng He; Frank Eriksson; Thomas H Scheike; Mei-Jie Zhang
Journal:  Scand Stat Theory Appl       Date:  2015-06-05       Impact factor: 1.396

10.  Absolute risk regression for competing risks: interpretation, link functions, and prediction.

Authors:  Thomas A Gerds; Thomas H Scheike; Per K Andersen
Journal:  Stat Med       Date:  2012-08-02       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.